The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.
AUSTIN, TX / ACCESS Newswire / January 20, 2026 / With millions of people suffering from chronic dehydration and fatigue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback